ResearchersLinks

Case Report · Volume 4, Issue 1, Pages 1–4, 22 November 2015 · Open Access

A Case Report on Invasive Ductal Carcinoma in Dog

· · · · · ·

Article Info ⌄
Journal:
Advances in Animal and Veterinary Sciences
Published:
22 November 2015

From the article

  • Keywords | Invasive ductal carcinoma, Dog, ER, HER2/neu, Mammary gland.
  • Tumours of the mammary gland are among the most common neoplasms in the dog, but little is known about familial canine neoplasia.
  • Studies have shown that several non-neoplastic mammary intraepithelial lesions have been associated with the development of invasive mammary carcinomas.
  • HER-2 and EGFR overexpression was associated with malignancy in canine mammary tumors.

Selected from the article's own text.

Abstract

Tofazzal Md. Rakib1*, Md. Shafiqul Islam1, Mohammad Mahbubur Rahman1, Amam Zonaed Siddiki1, Bibek Chandra Sutradhar2, Mohammad Alamgir Hossain1, Md. Masuduzzaman1

1Department of Pathology and Parasitology; 2Department of Medicine and Surgery, Chittagong Veterinary and Animal Sciences University, Chittagong, Bangladesh.

*Correspondence | Tofazzal Md. Rakib, Chittagong Veterinary and Animal Sciences University, Zakir Hossain Road, Khulshi-4225, Chittagong, Bangladesh; E-mail: rakibtofazzal367@gmail.com


Abstract
Invasive ductal carcinoma is the most common invasive breast cancer in both women and pets, while the mammary tumors are the second most frequent neoplasm in dogs. A 5 years old bitch was presented at Teaching Veterinary Hospital of Chittagong Veterinary and Animal Sciences University, Bangladesh, having hard lump with irregular borders at post umbilical region. The biopsy sample was taken followed by histopathology and ER, HER2/neu, Ki67 immunostaining was done to know the type and cell origin of the tumour. Pleomorphism, increased mitotic figure and metastasis were revealed in histopathology. The section gave higher response to ER, HER2/neu Ig where response to Ki67 was low indicating luminal type A invasive ductal carcinoma. Grading tumours by immunostaining aid in prognosis and therapy.

Keywords | Invasive ductal carcinoma, Dog, ER, HER2/neu, Mammary gland

Editor | Kuldeep Dhama, Indian Veterinary Research Institute, Uttar Pradesh, India.

Received | August 30, 2015; Revised | September 30, 2015; Accepted | October 01, 2015; Published | November 22, 2015

Citation | Rakib TM, Islam MS, Rahman MM, Siddiki AZ, Sutradhar BC, Hossain MA, Masuduzzaman M (2016). A case report on invasive ductal carcinoma in dog. Adv. Anim. Vet. Sci. 4(1): 1-4.

ISSN (Online) | 2307-8316; ISSN (Print) | 2309-3331

Copyright © 2016 Rakib et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

Acknowledgement

The author would like to thank Dr. Sharmin Chowdhury (Professor, Dept. of Pathology and Parasitology, CVASU) for providing financial support to complete the research work from HEQEP project (HEQEP CP: 3220); author would also like to thank Dr. Md. Zillur Rahman, Associate Professor, Department of Pathology, Chittagong Medical College, Bangladesh for providing technical support throughout the investigation process.

aUTHORS’ CONTRIBUTION

All the authors contributed equally.

Conflict of interest

There exisis no conflict of interest.

References

  1. Albain KS, Barlow WE, Shak S, Hortobagyi GN, Livingston RB, Yeh IT, Ravdin P, Bugarini R, Baehner FL, Davidson NE, Sledge GW, Winer EP, Hudis C, Ingle JN, Perez EA, Pritchard KI, Shepherd L, Gralow JR, Yoshizawa C, Allred DC, Osborne CK, Hayes DF (2010). Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: A retrospective analysis of a randomised trial. Lancet Oncol. 11(1): 55-65. http://dx.doi.org/10.1016/S1470-2045(09)70314-6[CrossRef]
  2. Alenza M, Pena L, Castillo ND, Niet AI (2000). Factors influencing the incidence and prognosis of canine mammary tumours. J. Small Anim. Pract. 41(7): 287-291. http://dx.doi.org/10.1111/j.1748-5827.2000.tb03203.x[CrossRef]
  3. Bertagnolli A, Ferreira E, Dias E, Cassali G (2011). Canine mammary mixed tumours: Immunohistochemical expressions of EGFR and HER‐2. Austral. Vet. J. 89(8): 312-317.
  4. Bhargava R, Gerald WL, Li AR, Pan Q, Lal P, Ladanyi M, Chen B (2005). EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations. Modern pathol. 18(8): 1027-1033. http://dx.doi.org/10.1038/modpathol.3800438[CrossRef]
  5. Dabbs DJ, Carter G, Fudge M, Peng Y, Swalsky P, Finkelstein S (2006). Molecular alterations in columnar cell lesions of the breast. Modern pathol. 19(3): 344-349. http://dx.doi.org/10.1038/modpathol.3800538[CrossRef]
  6. Dobson J, Samuel S, Milstein H, Rogers K, Wood J (2002). Canine neoplasia in the UK: Estimates of incidence rates from a population of insured dogs. J. Small Anim. Pract. 43(6):240-246. http://dx.doi.org/10.1111/j.1748-5827.2002.tb00066.x[CrossRef]
  7. Egenvall A, Bonnett BN, Öhagen P, Olson P, Hedhammar Å, von Euler H (2005). Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002. Prevent. Vet. Med. 69(1): 109-127. http://dx.doi.org/10.1016/j.prevetmed.2005.01.014[CrossRef]
  8. Freudenberg JA, Wang Q, Katsumata M, Drebinb J, Nagatomoa I, Greene MI (2009). The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies. Exp. Mol. Pathol. 87(1): 1-11. http://dx.doi.org/10.1016/j.yexmp.2009.05.001[CrossRef]
  9. Gama A, Gärtner F, Alves A, Schmitt F (2009). Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues. Res. Vet. Sci. 87(3): 432-437.
  10. Goldschmidt M, Pena L, Rasotto R, Zappulli V (2011). Classification and grading of canine mammary tumors. Vet. Pathol. Online. 48(1): 117-131.
  11. Hampe J, Misdorp W (1974). Tumours and dysplasias of the mammary gland. Bull. World Health Org. 50 (1-2): 111.
  12. Jacobs TW, Gown AM, Yaziji H, Barnes MJ, Schnitt SJ (2000). HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry a study of interlaboratory agreement. Am. J. Clin. Pathol. 113 2): 251-258.
  13. Leonard GD, Swain SM (2004). Ductal carcinoma in situ, complexities and challenges. J. Natl. Cancer Inst. 96(12): 906-920. http://dx.doi.org/10.1093/jnci/djh164[CrossRef]
  14. Misdorp W (2002). Tumors of the mammary gland. Tumors in Domestic Animals, Fourth Edition: 575-606. http://dx.doi.org/10.1002/9780470376928.ch12[CrossRef]
  15. Olopade OI, Grushko TA, Nanda R, Huo D (2008). Advances in breast cancer: Pathways to personalized medicine. Clin. Cancer Res. 14(24): 7988-7999.
  16. Owens MA, Horten BC, Da Silva MM (2004). HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues. Clin. Breast Cancer. 5(1): 63-69. http://dx.doi.org/10.3816/CBC.2004.n.011[CrossRef]
  17. Perou CM (2011). Molecular stratification of triple-negative breast cancers. Oncologist. 16(Supplement 1): 61-70. http://dx.doi.org/10.1634/theoncologist.2011-S1-61[CrossRef]
  18. Ross JS, Fletcher JA, Bloom KJ (2004). Targeted therapy in breast cancer the HER-2/neu gene and protein. Mol. Cell. Proteomics. 3(4): 379-398. http://dx.doi.org/10.1074/mcp.R400001-MCP200[CrossRef]
  19. Schneider R (1970). Comparison of age, sex, and incidence rates in human and canine breast cancer. Cancer. 26(2): 419-426. http://dx.doi.org/10.1002/1097-0142(197008)26:2<419::AID-CNCR2820260225>3.0.CO;2-U[CrossRef]
  20. Schwartz GF, Solin LJ, Olivotto IA, Ernster VL, Pressman PI (2000). Consensus conference on the classification of ductal carcinoma of the breast, April 22–25, 1999. Cancer. 88(4): 946-954. http://dx.doi.org/10.1002/(SICI)1097-0142(20000215)88:4<946::AID-CNCR26>3.0.CO;2-5[CrossRef]
  21. Stratmann N, Failing K, Richter A, Wehrend A (2008). Mammary tumor recurrence in bitches after regional mastectomy. Vet. Surg. 37(1): 82-86.
  22. Vail DM, Macewen EG (2000). Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest. 18(8): 781-792. http://dx.doi.org/10.3109/07357900009012210[CrossRef]

Services

Article usage statistics

Loading…